Outcome of the Board Meeting held on 08-08-2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Dipna Pharmachem met on 8th August 2025 and approved three items. First, a marginal increase in authorised share capital from Rs. 25 crore to Rs. 25.5 crore (an addition of 5 lakh equity shares of Rs. 10 each), to be reflected in the Memorandum of Association. Second, the Board approved the Director's Report for FY 2024-25 along with its annexures. Third, the 14th Annual General Meeting was scheduled for Saturday, 30th August 2025 at 4:00 PM, to be held via video conferencing. No dividend, bonus, stock split, or buyback was announced.
The authorised capital hike is very small (2%) and does not imply any immediate equity dilution or shareholder action. The AGM notice is a routine regulatory step, so neither item is likely to move the stock price.